Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
06/2014
06/03/2014US8741846 Storage-stable, functionally intact fibrinogen
06/03/2014US8741845 Lyophilized fibrin sealant for high volume hemorrhage
06/03/2014US8741844 Use of mutated antithrombins for treating or preventing coagulation disorders
06/03/2014US8741843 Compositions and methods for inducing angiogenesis
06/03/2014US8741842 Chimeric natriuretic polypeptides with unique pharmacologic profiles
06/03/2014US8741841 Fibroblast growth factor 21 proteins
06/03/2014US8741840 BMP-7 for use in treating neointimal hyperplasia
06/03/2014US8741839 Polypeptides targeting vascular endothelial growth factor receptor-2 and αvβ3 integrin
06/03/2014US8741838 Control of growth and repair of gastro-intestinal tissues by gastrokines and inhibitors
06/03/2014US8741837 HCV protease inhibitors and uses thereof
06/03/2014US8741836 Polypeptides
06/03/2014US8741835 Use of a ghrelin agonist to improve the catabolic effects of glucocorticoid treatment
06/03/2014US8741834 Dipeptoid prodrugs and the use thereof
06/03/2014US8741833 Self-assembling peptides incorporating modifications and methods of use thereof
06/03/2014US8741832 Pegylated albumin and uses thereof
06/03/2014US8741814 T cell receptor display
06/03/2014US8741629 Selective heated extraction of globulin proteins from intact freshwater algal cells
06/03/2014US8741621 Enhanced production and purification of a natural high intensity sweetener
06/03/2014US8741576 Heteroclitic analogs and related methods
06/03/2014US8741354 Composite extracellular matrix materials and medical products formed therefrom
06/03/2014US8741352 Graft materials containing ECM components, and methods for their manufacture
06/03/2014US8741307 Hybrid prokaryotic-eukaryotic tubulins and use thereof
06/03/2014US8741306 Kidney specific tumor vaccine directed against kidney tumor antigen G-250
06/03/2014US8741303 Immunogenic LHRH compositions and methods relating thereto
06/03/2014US8741296 Adenocarcinoma specific antibody SAM-6, and uses thereof
06/03/2014US8741291 Multifunctional antibody conjugates
06/03/2014US8741286 Serene protease derivatives and uses in the prevention or the treatment of blood coagulation disorders
06/03/2014US8741285 Method for treating a patient
06/03/2014US8741284 Crystallized oxalate decarboxylase and methods of use
06/03/2014US8741283 Adenosine deaminase anticancer therapy
06/03/2014US8741270 Bonding tissues and cross-linking proteins with naphthalimide compounds
06/03/2014US8741260 Fusion proteins for delivery of GDNF to the CNS
06/03/2014CA2799437C Method of producing hydroxyalkyl starch derivatives
06/03/2014CA2649982C Formulation comprising whey protein and hydrolysates for improving muscle recovery
06/03/2014CA2606871C Use of native peptides and their optimized derivatives for vaccination
06/03/2014CA2606515C Method of improving learning and memory in mammals
06/03/2014CA2587537C Use of depsipeptides for preventing vertical endoparasite infections
06/03/2014CA2563313C Modulation of nkg2d
06/03/2014CA2562767C Implantable pump for protein delivery for obesity control by drug infusion into the brain
06/03/2014CA2541240C Method for the production of a cell and/or tissue and/or disease phase specific medicament
06/03/2014CA2521410C Inhibitor proteins of a protease and use thereof
06/03/2014CA2497913C Use of chimeric nucleases to stimulate gene targeting
06/03/2014CA2496795C Compositions and methods for treating cardiovascular disease
06/03/2014CA2443995C Endothelial cell expression patterns
06/03/2014CA2412764C Stimulation of cellular regeneration and differentiation in the inner ear
06/03/2014CA2395892C Pharmaceutical formulation composed of a polymer blend and an active compound for time-controlled release
06/03/2014CA2370081C Lpl variant therapeutics
06/03/2014CA2361334C Deglycosylated kringle 1-3 region fragments of plasminogen and methods of use
05/2014
05/30/2014WO2014082042A2 Peptides that stimulate subcutaneous adipogenesis
05/30/2014WO2014081980A2 Mutant ngal proteins and uses thereof
05/30/2014WO2014081944A2 Egfr and c-met-fibronectin type iii domain binding molecules
05/30/2014WO2014081937A2 Oncolytic poliovirus for human tumors
05/30/2014WO2014081872A1 Improved peptide pharmaceuticals for insulin resistance
05/30/2014WO2014081864A1 Improved peptide pharmaceuticals
05/30/2014WO2014081849A1 Formulations of active agents for sustained release
05/30/2014WO2014081846A2 Pharmaceutical compositions and therapeutic methods of use comprising selective agonists of melanocortin 1 receptor
05/30/2014WO2014081845A2 Skin care compositions and methods comprising selective agonists of melanocortin 1 receptor
05/30/2014WO2014081772A1 Regeneration of coronary artery by coronary endothelial specific progenitor cells
05/30/2014WO2014081728A1 Inhibitors of the t cell-specific alternative p38 activation pathway and methods of use
05/30/2014WO2014081702A2 Synthetic linear apelin mimetics for the treatment of heart failure
05/30/2014WO2014080730A1 Glycosylated linker, compound containing glycosylated linker moiety and physiologically active substance moiety or salt thereof, and methods for producing said compound or salt thereof
05/30/2014WO2014080703A1 Modified galectin-9 protein
05/30/2014WO2014080401A2 Method of increasing the hydrodynamic volume of polypeptides by attaching to gonadotrophin carboxy terminal peptides
05/30/2014WO2014080376A2 Pro-pigmenting peptides
05/30/2014WO2014080162A1 Vip and an alpha-adrenergic blocker for use in the diagnosis of erectile dysfunction and vascular ischaemia
05/30/2014WO2014080161A1 Vip and an alpha-adrenergic blocker for use in the treatment of erectile dysfunction post radical prostatectomy
05/30/2014WO2014080063A1 Recombinant protein and uses thereof in the diagnosis of multiple sclerosis
05/30/2014WO2014079943A1 Cd44v6-derived peptides for treating metastasizing cancers
05/30/2014WO2014079940A1 Cd44v6-derived peptides for treating pancreatic cancer
05/30/2014WO2014079931A1 Cd44v6-derived peptides for treating breast cancers
05/30/2014WO2014079922A1 Composition for immediate and extended release
05/30/2014WO2014079914A1 Cd44v6-derived pegylated peptides
05/30/2014WO2014079689A1 Fibrinolytic compositions comprising bromelain and nattokinase for the prevention and treatment of phlebothrombotic states
05/30/2014WO2014079583A1 Chondramide derivatives
05/30/2014WO2014079464A1 A novel enzymes compositions for treatment of human immunodeficiency virus (hiv) infection
05/30/2014WO2014079399A1 Polypeptide antagonists of human il-23 receptor for treatment of autoimmune diseases
05/30/2014WO2014079384A1 Trophic hormone fusion protein, preparation method and application thereof
05/30/2014WO2014078935A1 Treatment of gluten intolerance and related conditions
05/30/2014WO2014078929A1 Topical formulation for the prevention and treatment of alopecia and for inhibiting hair growth
05/30/2014WO2014078900A1 Anti-pathogenic methods
05/30/2014WO2014078896A1 Complex-formation-modulating agents and uses therefor
05/30/2014WO2014078889A1 Improved inhibitors of grb7
05/30/2014WO2014045126A3 Treatment of pain by inhibition of usp5 de-ubiquitinase
05/30/2014WO2013184912A4 Binding agents that modulate the hippo pathway and uses thereof
05/30/2014WO2013059322A3 Amyloid beta peptide as a therapy for inflammation
05/30/2014WO2013029011A3 Methods and compositions comprising a c-terminal bax peptide
05/29/2014US20140148582 Nucleic acids encoding biologically active polypeptides derived from a novel early stage pregnancy factor designated maternin (ma)
05/29/2014US20140148395 Protease triggered release of molecules from hydrogels
05/29/2014US20140148391 Use of histones for therapeutic purposes
05/29/2014US20140148389 Methods for accelerating wound healing by administration of adipokines
05/29/2014US20140148387 Freeze-dried recombinant human bone morphogenetic protein-2 preparation
05/29/2014US20140148386 Method for prevention or treatment of diabetic vascular leakage-induced disease using C-peptide
05/29/2014US20140148385 Composition for preventing or treating erectile dysfunction comprising angiopoietin-4 protein
05/29/2014US20140148384 Use of ave0010 for the manufacture of a medicament for the treatment of diabetes mellitus type 2
05/29/2014US20140148381 Modified viral structural protein with antiviral activity
05/29/2014US20140147507 Carbide-derived-carbon-based oxygen carriers
05/29/2014US20140147500 Preparation and Use of Combination Enzyme and Gastrointestinal Modulator Delivery Systems
05/29/2014US20140147494 Delivery Substrates From Aligned Polymer Biomaterials For Tissue Repair
05/29/2014US20140147492 Methods and compositions for enhancing the uptake of therapeutic agents by target cells
05/29/2014US20140147491 Treatment of autism spectrum disorders using glycyl-l-2-methylprolyl-l-glutamic acid
1 ... 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 ... 3163